FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileREX Peptide ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PEPT
REX Peptide ETF ETF AnalysisComprehensive ETF analysis for REX Peptide ETF (PEPT) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisPEPT
PEPT
REX Peptide ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PEPT
  1. Home
  2. Screener
  3. REX Peptide ETFPEPTETF
REX Peptide ETF Logo

REX Peptide ETF

ETF
🇺🇸PEPT•NASDAQ•US Equity

Your view on PEPT

REX Peptide ETF Logo

REX Peptide ETF

ETFRexshares
🇺🇸PEPT•NASDAQ•US Equity
AUM (USD)$3.23M
Expense Ratio0.65%
Holdings35

Sentiment

—

AUM (USD)

$3.23M

Expense Ratio

0.65%

Holdings

35

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

REX Peptide ETF (PEPT) is an US Equity fund from Rexshares, listed since 2026, with $3.2M in assets under management, a 0.65% expense ratio and a NAV of $26.85 USD.

Overview for REX Peptide ETF

Fund Type
ETF
Fund Issuer
Rexshares
Asset Class
US Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 14, 2026
Domicile
US
Website
rexshares.com/PEPT
Fund Type
ETF
Fund Issuer
Rexshares
Asset Class
US Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 14, 2026
Domicile
US
Website
rexshares.com/PEPT
Fund Type
ETF
Fund Issuer
Rexshares
Asset Class
US Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 14, 2026
Domicile
US
Website
rexshares.com/PEPT

About this fund

The Fund seeks results that generally correspond to the price and yield of an index of companies in the peptides industry. It is a passively managed index ETF investing primarily in securities that comprise the index.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

US Equity

Expense Ratio

0.65%

AUM

$3.23M

Fund Details

NAV$26.85 USD
Holdings35
Average Volume7.8K
Inception DateOctober 14, 2026
Asset ClassUS Equity
Fund IssuerRexshares
DomicileUS
ISINUS7615627921
CUSIP761562792
NAV CurrencyUSD

Expense Ratio

0.65%

Assets Under Management

$3.23M

NAV

$26.85 USD

Holdings

35

Average Volume

7.8K

Inception Date

October 14, 2026

Asset Class

US Equity

Fund Issuer

Rexshares

Domicile

US

ISIN

US7615627921

CUSIP

761562792

NAV Currency

USD

Expense Ratio

0.65%

Assets Under Management

$3.23M

NAV

$26.85 USD

Holdings

35

Average Volume

7.8K

Inception Date

October 14, 2026

Asset Class

US Equity

Fund Issuer

Rexshares

Domicile

US

ISIN

US7615627921

CUSIP

761562792

NAV Currency

USD

Data last updated: Nov 20, 2026, 08:11 AM

Sectors

How the fund's assets are split across sectors.

10 sectors
  • 1Healthcare
    77.6%
  • 2Cash & Others
    9.2%
  • 3Financial Services
    6.1%
  • 4Consumer Defensive
    4.2%
  • 5Basic Materials
    2.2%
  • 6Industrials
    0.2%
  • 7Technology
    0.2%
  • 8Communication Services
    0.1%
  • 9Consumer Cyclical
    0.1%
  • 10Energy
    0.1%

Top sector

Healthcare

Top weight

77.6%

Top 3 weight

92.9%

Holdings

The securities the fund owns, by weight.

35 positions
1LLYELI LILLY & CO
13.52%
2ASNDASCENDIS PHARMA A/S COMMON STOCK
11.46%
3NVONovo Nordisk A/S ADR
9.93%
4PODDINSULET CORP
7.64%
5RYTMRHYTHM PHARMACEUTICALS INC
6.23%
6PTGXPROTAGONIST THERAPEUTICS INC
6.16%
7SANSANOFI
5.91%
8DARDarling Ingredients Inc
3.95%
9VKTXVIKING THERAPEUTICS INC
3.63%
10—BACHEM HOLDING LTD COMMON STOCK
3.59%
11—IPSEN
2.98%
12PBLSPARABILIS MEDICINES INC
2.71%
13ZEALZEALAND PHARMA A/S
2.52%
14AUPHAURINIA PHARMACEUTICALS INC
2.19%
15MBXMBX Biosciences Inc
2.00%

Concentration

Total Holdings35
Top 10 Weight72.01%
Top HoldingLLY
Top Weight13.52%
1LLYELI LILLY & CO
13.52%
2ASNDASCENDIS PHARMA A/S COMMON STOCK
11.46%
3NVONovo Nordisk A/S ADR
9.93%
4PODDINSULET CORP
7.64%
5RYTMRHYTHM PHARMACEUTICALS INC
6.23%
6PTGXPROTAGONIST THERAPEUTICS INC
6.16%
7SANSANOFI
5.91%
8DARDarling Ingredients Inc
3.95%
9VKTXVIKING THERAPEUTICS INC
3.63%
10—BACHEM HOLDING LTD COMMON STOCK
3.59%
11—IPSEN
2.98%
12PBLSPARABILIS MEDICINES INC
2.71%
13ZEALZEALAND PHARMA A/S
2.52%
14AUPHAURINIA PHARMACEUTICALS INC
2.19%
15MBXMBX Biosciences Inc
2.00%

Total Holdings

35

Top 10 Weight

72.01%

Top Holding

LLY

Top Weight

13.52%

1LLYELI LILLY & CO
13.52%$435.6K
2ASNDASCENDIS PHARMA A/S COMMON STOCK
11.46%$369.3K
3NVONovo Nordisk A/S ADR
9.93%$320.0K
4PODDINSULET CORP
7.64%$246.1K
5RYTMRHYTHM PHARMACEUTICALS INC
6.23%$200.7K
6PTGXPROTAGONIST THERAPEUTICS INC
6.16%$198.4K
7SANSANOFI
5.91%$190.6K
8DARDarling Ingredients Inc
3.95%$127.2K
9VKTXVIKING THERAPEUTICS INC
3.63%$117.1K
10—BACHEM HOLDING LTD COMMON STOCK
3.59%$115.6K
11—IPSEN
2.98%$96.2K
12PBLSPARABILIS MEDICINES INC
2.71%$87.3K
13ZEALZEALAND PHARMA A/S
2.52%$81.2K
14AUPHAURINIA PHARMACEUTICALS INC
2.19%$70.7K
15MBXMBX Biosciences Inc
2.00%$64.5K

Total Holdings

35

Top 10 Weight

72.01%

Top Holding

LLY

Top Weight

13.52%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on12 funds
FundAsset classExpense ratioAssetsHoldings
PEPTREX Peptide ETFThis fundUS Equity0.65%$3M35

More Rexshares ETFs

  • NVDQT-REX 2X Inverse NVIDIA Daily Target ETFUS Equity1.05%$16M5
  • NVDXT-REX 2X Long NVIDIA Daily Target ETFUS Equity1.05%$268M11
  • NVIIREX NVDA Growth & Income ETFUS Equity1.49%$72M7
  • RDWUETF Opportunities Trust - T-REX 2X Long RDW Daily Target ETFUS Equity1.50%$12M5
  • SPAXT-Rex 2X Long SpaceX Daily Target ETFUS Equity1.50%$50M7
  • TLDRThe Laddered T-Bill ETFUS Equity0.20%$7M2
  • TSIIREX TSLA Growth & Income ETFUS Equity1.52%$29M6
  • TSLTT-REX 2X Long Tesla Daily Target ETFUS Equity1.05%$135M11
  • TSLZT-REX 2X Inverse Tesla Daily Target ETFUS Equity1.05%$23M7
  • ULTIREX IncomeMax Option Strategy ETFUS Equity1.32%$9M1
  • WMTIREX WMT Growth & Income ETFUS Equity0.99%$10M6
  • AAPXT-REX 2X Long Apple Daily Target ETFUS Equity1.05%$7M5
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News